<p>Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer</p>
Yanmei Wu(Guangdong Medical College), Yuan Sheng(Changhai Hospital)
Cited by 53
Related Papers
Germline mutations in 40 cancer susceptibility genes among <scp>C</scp>hinese patients with high hereditary risk breast cancer
|International Journal of Cancer|2018|61